With Molina Healthcare Stock Sliding, Have You Assessed The Risk?
Molina Healthcare (MOH) stock is down 25.5% in a day. The recent slide reflects renewed concerns around Molina Healthcare’s Q4 loss, weak 2026 outlook, and rising medical costs in Medicaid, but sharp drops like this often raise a tougher question: is the weakness temporary, or a sign of deeper cracks in the story?
Before judging its downturn reslience, let’s look at where Molina Healthcare stands today.
- Size: Molina Healthcare is a $6.9 Bil company with $45 Bil in revenue currently trading at $131.72.
- Fundamentals: Last 12 month revenue growth of 13.7% and operating margin of 3.0%.
- Liquidity: Has Debt to Equity ratio of 0.56 and Cash to Assets ratio of 0.54
- Valuation: Molina Healthcare stock is currently trading at P/E multiple of 7.8 and P/EBIT multiple of 5.2
- Has returned (median) 28.1% within a year following sharp dips since 2010. See MOH Dip Buy Analysis.
These metrics point to a Moderate operational performance, alongside Very Low valuation – making the stock Attractive. For details, see Buy or Sell MOH Stock
That brings us to the key consideration for investors worried about this fall: how resilient is MOH stock if markets turn south? This is where our downturn resilience framework comes in. Suppose MOH stock falls another 20-30% to $92 – can investors comfortably hold on? Turns out, the stock saw an impact slightly better than the S&P 500 index during various economic downturns, based on (a) how much the stock fell and, (b) how quickly it recovered. Below, we dive deeper into each such downturn.
- Palantir At 80x Earnings: What Revenue Growth Rate Justifies The Valuation?
- Should You Pay Attention To Chevron Stock’s Momentum?
- What Is Happening With Caterpillar Stock?
- What Can Trigger Microsoft Stock’s Slide?
- Is Microsoft Stock A Trap Or A Missed Opportunity?
- Earn 9.6% Today or Buy BSX 30% Cheaper – It’s a Win-Win

2022 Inflation Shock
- MOH stock fell 29.4% from a high of $369.23 on 26 October 2022 to $260.64 on 15 March 2023 vs. a peak-to-trough decline of 25.4% for the S&P 500.
- However, the stock fully recovered to its pre-Crisis peak by 12 December 2023
- Since then, the stock increased to a high of $419.53 on 19 March 2024 , and currently trades at $131.72
| MOH | S&P 500 | |
|---|---|---|
| % Change from Pre-Recession Peak | -29.4% | -25.4% |
| Time to Full Recovery | 272 days | 464 days |
2020 Covid Pandemic
- MOH stock fell 29.9% from a high of $153.84 on 19 February 2020 to $107.79 on 23 March 2020 vs. a peak-to-trough decline of 33.9% for the S&P 500.
- However, the stock fully recovered to its pre-Crisis peak by 8 April 2020
| MOH | S&P 500 | |
|---|---|---|
| % Change from Pre-Recession Peak | -29.9% | -33.9% |
| Time to Full Recovery | 16 days | 148 days |
2018 Correction
- MOH stock fell 30.8% from a high of $155.28 on 6 June 2019 to $107.47 on 27 September 2019 vs. a peak-to-trough decline of 19.8% for the S&P 500.
- However, the stock fully recovered to its pre-Crisis peak by 8 April 2020
| MOH | S&P 500 | |
|---|---|---|
| % Change from Pre-Recession Peak | -30.8% | -19.8% |
| Time to Full Recovery | 194 days | 120 days |
2008 Global Financial Crisis
- MOH stock fell 59.0% from a high of $27.22 on 24 December 2007 to $11.17 on 12 December 2008 vs. a peak-to-trough decline of 56.8% for the S&P 500.
- However, the stock fully recovered to its pre-Crisis peak by 4 April 2011
| MOH | S&P 500 | |
|---|---|---|
| % Change from Pre-Recession Peak | -59.0% | -56.8% |
| Time to Full Recovery | 843 days | 1,480 days |
Feeling jittery about MOH stock? Consider portfolio approach.
A Multi Asset Portfolio Gives You Safer Smarter Growth
Individual stocks can soar or tank but multi asset exposure steadies the ride. A spread out portfolio captures upside while limiting the damage from any one market.
The asset allocation framework of Trefis’ Boston-based, wealth management partner yielded positive returns during the 2008-09 period when the S&P lost more than 40%. Our partner’ strategy now includes Trefis High Quality Portfolio, which has a track record of comfortably outperforming its benchmark that includes all 3 – the S&P 500, S&P mid-cap, and Russell 2000 indices